Eloxx Pharmaceuticals Inc (Eloxx Pharmaceuticals Inc (ELOX) was up Monday morning, with the stock adding 3.70% pre-trade to 1.4.
ELOX’s short-term technical score of 4 indicates that the stock has traded less bullish in the past month than 96% of the stocks in the market. In the biotech industry, which ranks 141st out of 146 industries, stock ranks above 10% of stocks.
Eloxx Pharmaceuticals Inc fell 46.85% over the past month, closing at $ 2.30 on April 19. During this time, the stock has fallen as low as $ 1.35 and as high as $ 2.59. ELOX has an average buy analyst recommendation. The company has an average price target of $ 4.50.
Eloxx Pharmaceuticals Inc has a Long Term Technical Rank of 0. This means that trading in the last 200 trading days placed the company in the bottom half of the stocks with 100% of the market with a higher score. In the biotechnology industry, number 142 according to this metric, ELOX ranks better than 1% of stocks.
Important dates for investors in ELOX:
-Eloxx Pharmaceuticals Inc is expected to report its results on 8/5/2021. In its last earnings release, the company posted EPS of $ -0.73. – We do not have a fixed dividend date for Eloxx Pharmaceuticals Inc at this time. Click here for the full Eloxx Pharmaceuticals Inc (ELOX) stock quote report.